Figure 5
Figure 5. Eosinophils recruited in response to Af antigens are activated and degranulate in response to PVM and promote antiviral activity. (A) mEPX was detected in BAL fluid from Af-sensitized and Af-challenged, PVM-infected B6 wild-type mice only; n = 4 to 8 mice per group; ***P < .0001 vs Af-sensitized and Af-challenged, but not PVM-infected, group, as well as all other conditions. (B) RNase activity was detected in BAL fluid from Af-sensitized and Af-challenged, PVM-infected wild-type B6 mice only; n = 4 to 8 mice per group; ***P < .0001 vs Af-sensitized and Af-challenged, but not PVM-infected, group, as well as all other conditions. (C) Transmission electron micrograph of an eosinophil isolated from the airways of an Af-sensitized and Af-challenged, PVM-infected wild-type B6 mouse. Indicated in the image are specific granules and vesiculotubular structures34 analogous to those described in human eosinophils (at the large arrow); original magnification ×23 000. (D) Virus recovery from Af-sensitized and -challenged and control B6 wild-type or B6 eosinophil–deficient ΔdblGATA mice at 4 days after inoculation with PVM (see Figure 4A for timeline).

Eosinophils recruited in response to Af antigens are activated and degranulate in response to PVM and promote antiviral activity. (A) mEPX was detected in BAL fluid from Af-sensitized and Af-challenged, PVM-infected B6 wild-type mice only; n = 4 to 8 mice per group; ***P < .0001 vs Af-sensitized and Af-challenged, but not PVM-infected, group, as well as all other conditions. (B) RNase activity was detected in BAL fluid from Af-sensitized and Af-challenged, PVM-infected wild-type B6 mice only; n = 4 to 8 mice per group; ***P < .0001 vs Af-sensitized and Af-challenged, but not PVM-infected, group, as well as all other conditions. (C) Transmission electron micrograph of an eosinophil isolated from the airways of an Af-sensitized and Af-challenged, PVM-infected wild-type B6 mouse. Indicated in the image are specific granules and vesiculotubular structures34  analogous to those described in human eosinophils (at the large arrow); original magnification ×23 000. (D) Virus recovery from Af-sensitized and -challenged and control B6 wild-type or B6 eosinophil–deficient ΔdblGATA mice at 4 days after inoculation with PVM (see Figure 4A for timeline).

Close Modal

or Create an Account

Close Modal
Close Modal